M. Bonnet

发表

Gut microbiota imbalance and colorectal cancer.

N. Barnich, D. Pezet, J. Gagnière, 2016, World journal of gastroenterology.

Internal dosimetry through GATE simulations of preclinical radiotherapy using a melanin-targeting ligand

N. Moins, J. Papon, J. Chezal, 2014, Physics in medicine and biology.

Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [18F]ICF01006, a highly promising melanoma PET tracer

N. Moins, J. Chezal, E. Miot-Noirault, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Amino‐acid change in the Epstein‐Barr‐virus zebra protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa

D. Martel-Renoir, A. Durandy, M. Levrero, 1998, International journal of cancer.

Evaluation of new iodinated acridine derivatives for targeted radionuclide therapy of melanoma using 125I, an Auger electron emitter

N. Moins, J. Papon, J. Madelmont, 2011, Investigational New Drugs.

Targeting the Tetraspanins with Monoclonal Antibodies in Oncology: Focus on Tspan8/Co-029

Yingying Zhu, M. Bonnet, C. Boucheix, 2019, Cancers.

Deciphering the immune microenvironment of a tissue by digital imaging and cognition network

N. Barnich, M. Bonnet, S. Naimi, 2018, Scientific Reports.

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms

D. Ardid, H. Sokol, C. Godfraind, 2022, Gut Microbes.

[123I]ICF01012 melanoma imaging and [131I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma models

F. Mishellany, J. Chezal, E. Miot-Noirault, 2015, European Journal of Dermatology.

Annexin A1 in primary tumors promotes melanoma dissemination

L. Ouchchane, J. Papon, Jean Kanitakis, 2014, Clinical & Experimental Metastasis.

Determination of biomarkers associated with neoadjuvant treatment response focusing on colibactin-producing Escherichia coli in patients with mid or low rectal cancer: a prospective clinical study protocol (MICARE)

P. Colombo, P. Rouanet, N. Barnich, 2022, BMJ Open.

B16 melanoma secretomes and in vitro invasiveness: syntenin as an invasion modulator

N. Moins, J. Chezal, M. Bonnet, 2010, Melanoma research.

TERMINOLOGY CONCEPTS OF PROBIOTIC AND PREBIOTIC AND THEIR ROLE IN HUMAN AND ANIMAL HEALTH

S. Salminen, M. Bonnet, C. L. L. Ferreira, 2011 .

Microbial markers in colorectal cancer detection and/or prognosis

N. Barnich, J. Gagnière, J. Veziant, 2018, World journal of gastroenterology.

Colonization of the Human Gut by E. coli and Colorectal Cancer Risk

Emmanuel Buc, Richard Bonnet, Pierre Sauvanet, 2013, Clinical Cancer Research.

Efficient and reproducible experimental infections of rats with Blastocystis spp.

D. Ardid, N. Barnich, M. Bonnet, 2018, PloS one.

Molecular Mechanism Underlying the Actions of Antioxidant Molecules in Digestive Disorders

J. Gagnière, M. Bonnet, 2017 .

Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-producing Escherichia coli in ApcMin/+ Mice.

P. Rosenstiel, C. Godfraind, G. Dalmasso, 2020, Gastroenterology.

Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer.

N. Barnich, D. Pezet, J. Gagnière, 2017, Clinical science.

Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imaging.

N. Barnich, D. Pezet, J. Gagnière, 2016, World journal of clinical oncology.

Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype

G. Dalmasso, D. Pezet, H. Wodrich, 2014, Gut.

Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation.

D. Pezet, J. Raisch, R. Bonnet, 2014, World journal of gastroenterology.

Intestinal Microbiota: A Novel Target to Improve Anti-Tumor Treatment?

N. Barnich, J. Gagnière, J. Veziant, 2019, International journal of molecular sciences.

Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer

N. Barnich, J. Veziant, M. Bonnet, 2021, Cancers.

Prognostic value of a combination of innovative factors (gut microbiota, sarcopenia, obesity, metabolic syndrome) to predict surgical/oncologic outcomes following surgery for sporadic colorectal cancer: a prospective cohort study protocol (METABIOTE)

C. Godfraind, N. Barnich, L. Cassagnes, 2020, BMJ Open.

Colibactin‐positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer

N. Barnich, D. Pezet, J. Veziant, 2020, International journal of cancer.

In vivo efficacy of melanoma internal radionuclide therapy with a 131I‐labelled melanin‐targeting heteroarylcarboxamide molecule

F. Penault-Llorca, N. Moins, J. Papon, 2013, International journal of cancer.

Anti‐melanoma efficacy of internal radionuclide therapy in relation to melanin target distribution

F. Penault-Llorca, N. Moins, J. Papon, 2010, Pigment cell & melanoma research.

Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer

P. Opolon, O. Bawa, I. Navarro-Teulon, 2017, Oncotarget.

The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not in the hippocampus in the TgCRND8 mouse model of Alzheimer’s disease

J. McLaurin, R. Quirion, J. Chabot, 2014, BMC Neuroscience.

Gut microbiota imbalance and colorectal cancer 2016 Colorectal Cancer : Global view

N. Barnich, D. Pezet, J. Gagnière, 2016 .

Human Cancer Biology Colonization of the Human Gut by E . coli and Colorectal Cancer Risk

D. Pezet, R. Bonnet, E. Buc, 2014 .

Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats

D. Ardid, C. Godfraind, M. Meleine, 2020, Scientific Reports.

Annexin A1 in primary tumors promotes melanoma dissemination

L. Ouchchane, J. Papon, Jean Kanitakis, 2014, Clinical & Experimental Metastasis.

Probiotics/Synbiotics to Reduce Infectious Complications after Colorectal Surgery: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

J. Veziant, M. Bonnet, B. Occean, 2022, Nutrients.

Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice

C. Godfraind, G. Dalmasso, N. Barnich, 2023, Gut microbes.

Detection of Epstein-Barr virus in invasive breast cancers.

E. Kremmer, I. Joab, M. Bonnet, 1999, Journal of the National Cancer Institute.

P29 New heteroaromatic compounds for a targeted melanoma therapy: factors modulating subcellular distribution

N. Moins, J. Papon, J. Madelmont, 2010 .

[How some commensal bacteria would exacerbate colorectal carcinogenesis?].

G. Dalmasso, N. Barnich, J. Raisch, 2016, Medecine sciences : M/S.

Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype

G. Dalmasso, D. Pezet, H. Wodrich, 2014, Gut.

The colibactin-producing Escherichia coli alters the tumor microenvironment to immunosuppressive lipid overload facilitating colorectal cancer progression and chemoresistance

I. Sobhani, I. Fournier, M. Chamaillard, 2023, bioRxiv.

Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice

M. Meleine, Y. Aissouni, W. D. de Vos, 2024, Gut microbes.